Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
Ophthalmic cataract surgery device - imass
2024

Share:

Ophthalmic cataract surgery device - imass

Ophthalmic medical devices

TI Inc.

The 'imass' is a surgical instrument developed to uniformly dissect the anterior capsule, the most important procedure in the first stage of cataract surgery. Its simple design ensures patient safety and ease of use by medical doctors as the top priority. Conventional continuous curvilinear capsulorrhexis (CCC), the most commonly used procedure in cataract surgery, significantly affects the future vision prognosis because the Incision of the anterior lens capsule shape and size are not uniform. Therefore, doctors can use 'imass' and its procedure to complete the CCC safely and quickly to satisfy both patients and medical staff.

Date of Launch
2024
Development Time
more than 24 Month
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumers / Users, "Cataract Patients / Eye Doctor"

RELATED PROJECTS